We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
Cap. Flow
-$1.58B
Cap. Flow %
-0.53%
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1B
2
AAPL icon
Apple
AAPL
+$797M
3
MRK icon
Merck
MRK
+$316M
4
AMZN icon
Amazon
AMZN
+$308M
5
MDT icon
Medtronic
MDT
+$298M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Healthcare 13.29%
3 Consumer Discretionary 13.23%
4 Financials 12.2%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RESN
2751
DELISTED
Resonant Inc.
RESN
$1.08M ﹤0.01%
407,038
+153,959
+61% +$364K
GNSS icon
2752
Genasys
GNSS
$79.2M
$1.07M ﹤0.01%
164,602
+818
+0.5% +$5.28K
ASO icon
2753
Academy Sports + Outdoors
ASO
$2.98B
$1.07M ﹤0.01%
+51,720
New +$838K
CATO icon
2754
Cato Corp
CATO
$66.1M
$1.07M ﹤0.01%
111,797
+11,409
+11% +$90K
AKUS
2755
DELISTED
Akouos Inc
AKUS
$1.07M ﹤0.01%
53,856
-110
-0.2% -$2.14K
LITS
2756
Lite Strategy Inc
LITS
$30.9M
$1.07M ﹤0.01%
20,215
+64
+0.3% +$3.69K
NRIM icon
2757
Northrim BanCorp
NRIM
$587M
$1.06M ﹤0.01%
125,560
+788
+0.6% +$6.23K
APYX icon
2758
Apyx Medical
APYX
$171M
$1.06M ﹤0.01%
147,625
+706
+0.5% +$4.68K
TARO
2759
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$1.06M ﹤0.01%
+14,424
New +$927K
CVLG icon
2760
Covenant Logistics
CVLG
$872M
$1.06M ﹤0.01%
142,860
-62,562
-30% -$525K
SEI
2761
Solaris Energy Infrastructure
SEI
$3.82B
$1.06M ﹤0.01%
129,783
+768
+0.6% +$5.48K
AFIB
2762
DELISTED
Acutus Medical Inc
AFIB
$1.06M ﹤0.01%
36,697
-75
-0.2% -$2.03K
WMC
2763
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$1.05M ﹤0.01%
32,248
+4,587
+17% +$124K
EBTC
2764
DELISTED
Enterprise Bancorp
EBTC
$1.05M ﹤0.01%
41,059
+7,865
+24% +$193K
LCI
2765
DELISTED
Lannett Company, Inc.
LCI
$1.04M ﹤0.01%
39,927
+5
+0% +$131
SMMF
2766
DELISTED
Summit Financial Group, Inc.
SMMF
$1.04M ﹤0.01%
47,158
+4,859
+11% +$95.7K
MCRB icon
2767
Seres Therapeutics
MCRB
$48.4M
$1.04M ﹤0.01%
11,167
+198
+2% +$116K
ACIC icon
2768
American Coastal Insurance
ACIC
$493M
$1.04M ﹤0.01%
181,105
-38,187
-17% -$193K
PRTK
2769
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.03M ﹤0.01%
165,273
-20,987
-11% -$124K
CNR
2770
Core Natural Resources Inc
CNR
$4.45B
$1.02M ﹤0.01%
142,122
-5,121
-3% -$26.8K
SFST icon
2771
Southern First Bancshares
SFST
$600M
$1.02M ﹤0.01%
28,937
+275
+1% +$8.47K
MRNS
2772
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1.02M ﹤0.01%
83,901
-4,682
-5% -$65.3K
ZYME icon
2773
Zymeworks
ZYME
$1.67B
$1.02M ﹤0.01%
21,576
+5,156
+31% +$239K
BATRA icon
2774
Atlanta Braves Holdings Series A
BATRA
$3.43B
$1.02M ﹤0.01%
40,879
+3,369
+9% +$80.2K
TNAV
2775
DELISTED
Telenav Inc.
TNAV
$1.01M ﹤0.01%
215,797
-716
-0.3% -$3.23K

Similar funds

Nuveen's Q4 2020 Portfolio in Review

As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
  • Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
  • Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
  • Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
  • Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
  • Nuveen opened 145 new positions and closed 125 in Q4 2020.
  • Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.